By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Q10-Q18 Congenital anomalies [malformations] of the eye, ear, face and neck

AddAnalogsCompare
Found partially in the 24 (15) ⓘFound partially in the 24 drug (15 of these, according to Kiberis statistics) in 43 selected books (authors) ... hide
  Effect Influence Cases ⓘ  Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • q10-q18 congenital anomalies [malformations] of the eye, ear, face and neck
  • 57%+30%21 read Chininum sulphuricum
    Eyes - E 47% (I 19%, 7 cases.); Face - E 66% (I 40%, 21 cases.)
  • 45%+12%28 read Colocynthis
    Eyes - E 45% (I 11%, 14 cases.); Face - E 46% (I 7%, 28 cases.); Neck - E 42% (I 16%, 12 cases.)
  • 43%+17%45 read Stramonium
    Eyes - E 64% (I 28%, 14 cases.); Face - E 22% (I 6%, 45 cases.)
  • 39%+11%87 read Gelsemium sempervirens
    Eyes - E 38% (I 4%, 40 cases.); Face - E 33% (I 7%, 87 cases.); Neck - E 44% (I 22%, 26 cases.)
  • 36%+3%382 read Arsenicum album
    Eyes - E 33% (I 1%, 159 cases.); Face - E 35% (I 2%, 382 cases.); Neck - E 39% (I 4%, 98 cases.)
  • 35%+3%64 read Spigelia anthelmia
    Eyes - E 55% (I 15%, 39 cases.); Face - E 37% (I 7%, 64 cases.); Neck - E 13% (I -14%, 19 cases.)
  • 35%+8%36 read Chamomilla vulgaris
    Eyes - E 29% (I 5%, 11 cases.); Face - E 40% (I 10%, 36 cases.)
  • 34%+3%232 read Rhus toxicodendron
    Eyes - E 35% (I 1%, 124 cases.); Face - E 35% (I 0%, 232 cases.); Neck - E 32% (I 8%, 81 cases.)
  • 33%+5%19 read Glonoinum
    Eyes - E 29% (I 8%, 15 cases.); Face - E 39% (I -3%, 19 cases.); Neck - E 29% (I 9%, 11 cases.)
  • 33%+7%74 read Spongia tosta
    Eyes - E 24% (I 8%, 16 cases.); Face - E 35% (I 5%, 74 cases.); Neck - E 40% (I 7%, 19 cases.)
  • 30%+3%479 read Lycopodium clavatum
    Eyes - E 29% (I -1%, 175 cases.); Face - E 35% (I 4%, 479 cases.); Neck - E 26% (I 4%, 103 cases.)
  • 29%+-0%139 read Belladonna
    Eyes - E 30% (I -2%, 60 cases.); Face - E 33% (I 6%, 139 cases.); Neck - E 22% (I -5%, 25 cases.)
  • 27%+2%256 read Thuja occidentalis
    Eyes - E 26% (I 5%, 123 cases.); Face - E 31% (I 3%, 256 cases.); Neck - E 24% (I -3%, 75 cases.)
  • 23%+2%11 read Vipera berus
    Eyes - E 13% (I 0%, 5 cases.); Face - E 32% (I 3%, 11 cases.)
  • 14%+5%42 read Hyoscyamus niger
    Eyes - E 2% (I -3%, 10 cases.); Face - E 25% (I 12%, 42 cases.)
  • Abrus precatorius read
  • Antipyrinum read
  • Chloralum hydratum read
  • Daphne indica read
  • Iodoformum read
  • Lyssinum read
  • Ozonum read
  • Sacharum lactis read
  • Strychninum purum read

Tree of ICD-10 diagnoses

  1. Description
  2. Related diseases
  3. Related clinical guidelines
  4. Related standards of medical care
  5. Basic medical services
  6. Clinics for treatment

Other names and synonyms

Q10-Q18.

Description

There is no detailed description, see related

Related diseases

Related clinical guidelines

Related standards of medical care

42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.


  1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
  2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
  3. Nothing in the information provided should be interpreted as a call to use these drugs.
  4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.